Google+ Badge

Thursday, July 30, 2015

Cancer Research: Anti-inflammatory drug acts against ovarian cancer ♦ Prostate cancer is five different diseases ♦ Red grape chemical may help prevent bowel cancer

New tool uses 'drug spillover' to match cancer patients with treatments A new article describes a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker predicts what genetics are truly driving the cancer in any population of cells and chooses the best 'kinase inhibitor' to silence these dangerous genetic causes of disease
Anti-inflammatory drug acts against ovarian cancer A non-steroidal anti-inflammatory drug (NSAID) called ketorolac helped women with ovarian cancer to survive longer, researchers report. Ketorolac, marketed as Toradol®, is approved for clinical use in the United States for pain after surgery.
Prostate cancer is five different diseases Scientists have, for the first time, identified that there are five distinct types of prostate cancer and have found a way to distinguish between them.
Targeted therapy shows effectiveness against a subtype of the brain tumor medulloblastoma A subset of medulloblastoma tumors briefly stopped growing or disappeared entirely during treatment with vismodegib, researchers report after a trial with both adults and children.
Red grape chemical may help prevent bowel cancer but less is more Resveratrol, a chemical found in red grapes, is more effective in smaller doses at preventing bowel cancer in mice than high doses, according to new research. Previous research looked at high doses of purified resveratrol to study its potential to prevent cancer. This is the first study to look at the effects of a lower daily dose -- equivalent to the amount of resveratrol found in one large (approx. 250ml) glass of red wine -- comparing it with a dose 200 times higher.

No comments:

Post a Comment